Despite the interaction between DSCAM-AS1 and hnRNPL at BCL2, 3′UTR deserves further experimental validations, and DSCAM-AS1 represents a good candidate to regulate this process in luminal breast cancer cells. The gene discussed is BCL2; the disease is breast carcinoma.